Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial
PIONEER 12 是一项双盲、IIIa 期、随机试验,旨在比较口服索玛鲁肽与西格列汀在二甲双胍控制不佳的 2 型糖尿病患者(主要为中国人群)中的疗效和安全性。
期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-024-06133-4
Ji, Linong; Agesen, Rikke M; Bain, Stephen C; Fu, Fangming; Gabery, Sanaz; Geng, Jianlin; Li, Yiming; Lu, Yibing; Luo, Bifen; Pang, Wuyan; Tao, Yi